Logo image of AACT

ARES ACQUISITION CORP II (AACT) Stock Fundamental Analysis

USA - NYSE:AACT - KYG330331045 - Common Stock

9.49 USD
+0.61 (+6.87%)
Last: 9/24/2025, 8:04:00 PM
9.81 USD
+0.32 (+3.37%)
After Hours: 9/24/2025, 8:04:00 PM
Fundamental Rating

1

AACT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. AACT may be in some trouble as it scores bad on both profitability and health. AACT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AACT was profitable.
AACT had a negative operating cash flow in the past year.
AACT Yearly Net Income VS EBIT VS OCF VS FCFAACT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

1.2 Ratios

Industry RankSector Rank
ROA 2.91%
ROE 3.06%
ROIC N/A
ROA(3y)2.64%
ROA(5y)N/A
ROE(3y)2.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AACT Yearly ROA, ROE, ROICAACT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AACT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AACT Yearly Profit, Operating, Gross MarginsAACT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, AACT has about the same amount of shares outstanding.
Compared to 1 year ago, AACT has an improved debt to assets ratio.
AACT Yearly Shares OutstandingAACT Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
AACT Yearly Total Debt VS Total AssetsAACT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

AACT has an Altman-Z score of 12.91. This indicates that AACT is financially healthy and has little risk of bankruptcy at the moment.
AACT has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 12.91
ROIC/WACCN/A
WACCN/A
AACT Yearly LT Debt VS Equity VS FCFAACT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 0.23 indicates that AACT may have some problems paying its short term obligations.
AACT has a Quick Ratio of 0.23. This is a bad value and indicates that AACT is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.23
Quick Ratio 0.23
AACT Yearly Current Assets VS Current LiabilitesAACT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

AACT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.98%.
EPS 1Y (TTM)-42.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-94.97%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 36.50 indicates a quite expensive valuation of AACT.
The average S&P500 Price/Earnings ratio is at 27.08. AACT is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 36.5
Fwd PE N/A
AACT Price Earnings VS Forward Price EarningsAACT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AACT Per share dataAACT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AACT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARES ACQUISITION CORP II

NYSE:AACT (9/24/2025, 8:04:00 PM)

After market: 9.81 +0.32 (+3.37%)

9.49

+0.61 (+6.87%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-04 2025-08-04
Earnings (Next)11-10 2025-11-10
Inst OwnersN/A
Inst Owner Change-4.89%
Ins OwnersN/A
Ins Owner Change100%
Market Cap587.05M
Revenue(TTM)N/A
Net Income(TTM)16.33M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 36.5
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 1.1
EV/EBITDA N/A
EPS(TTM)0.26
EY2.74%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS8.63
TBVpS8.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.91%
ROE 3.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.64%
ROA(5y)N/A
ROE(3y)2.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.23
Quick Ratio 0.23
Altman-Z 12.91
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-94.97%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-457.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.25%
OCF growth 3YN/A
OCF growth 5YN/A

ARES ACQUISITION CORP II / AACT FAQ

What is the fundamental rating for AACT stock?

ChartMill assigns a fundamental rating of 1 / 10 to AACT.


Can you provide the valuation status for ARES ACQUISITION CORP II?

ChartMill assigns a valuation rating of 0 / 10 to ARES ACQUISITION CORP II (AACT). This can be considered as Overvalued.


How profitable is ARES ACQUISITION CORP II (AACT) stock?

ARES ACQUISITION CORP II (AACT) has a profitability rating of 0 / 10.


What is the financial health of ARES ACQUISITION CORP II (AACT) stock?

The financial health rating of ARES ACQUISITION CORP II (AACT) is 2 / 10.